Ginkgo Bioworks Holdings, Inc.

DNA·NYSE·Healthcare
Compare
11.65+0.89 (+8.27%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market11.68+0.03 (+0.24%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.76
Open10.90
Day range10.7611.77
52-week range5.3718.22
Off day high−1.02%
Off 52-week high−36.06%
Volume2.69M
Avg. volume (3M)2.28M
Market cap784.51M
EPS (TTM)-5.06
Forward P/E-4.02
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.74
Shares outstanding55.38M
Short interest15.46% of float
Earnings dateNov 5, 2026
Analyst target8.00
Profit margin−219.61%

Against its peers

Compare in full ›
DNA GENB TECH SANA 688238.SS GENO.ST
Market cap 784.51M 1.82B 11.42B 766.36M 4.36B 1.47B
P/E (TTM) — — 62.7 — — 72.8
Forward P/E -4.0 -6.2 31.5 -4.6 — 46.5
Price/book 1.8 4.0 5.4 5.0 3.3 4.8
Dividend yield — — 0.44% — — —
1-year change −7.16% +9.49% +25.01% −36.79% −14.27% −4.08%
Today +8.27% +2.24% +0.10% +4.92% +5.49% +3.31%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All DNA news ›
Stock Titan·Positive

Assembly Biosciences officer proposes $50.9K stock sale

Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue Growth of 96% Y/Y; Raises FY 2026 Revenue Guidance to 91% Y/Y Growth and U.S. Comm Revenue Guidance to 143% Y/Y, Crushing Consensus Expectations Aehr Test Systems…

Stock Titan·

MeiraGTx officer proposes sale of 56,000 shares

GameSquare Announces The "Grand Theft Auto" Effect Supermicro Provides First Quarter of Fiscal Year 2027 Preliminary Business Update Cipher Digital Announces Date of Third Quarter 2026 Business Update Conference Call The securities…

Stock Titan·Positive

Cytokinetics officer proposes $1.03M share sale

Netflix Reports Q3 2026 Earnings: Revenue Rises 12% to $12.87 Billion, Operating Margin 34.6% INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science Peraso Receives Production Order Exceeding $2.0…

StocksToTrade·Negative

DNA Surges As Ginkgo Bioworks Lands Key AI Drug Deals

Ginkgo Bioworks Holdings Inc. stocks have been trading up by 14.81 percent amid heightened optimism over its synthetic biology platform What Traders Need To Know New data-generation agreement with Eli Lilly’s TuneLab embeds Ginkgo Bioworks…

Seeking Alpha·Negative

Ginkgo Bioworks: The Valuation Has Outrun The Business

Ginkgo Bioworks receives a reiterated 'Sell' rating, as recent AI/biotech enthusiasm has driven the stock far ahead of fundamentals. Learn more about DNA stock here. - Ginkgo Bioworks receives a reiterated 'Sell' rating, as recent…

From the 4Search news index, newest first.

In the news

21mentions in 30 days
16with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance